Wang, Jia, Sun, Chengxin, Zheng, Yan et al. · Archives of pharmacal research · 2014 · DOI
Researchers tested a compound extracted from ginseng called WGPA-A in mice to see if it could help reduce fatigue. They found that mice given WGPA-A could swim longer before becoming tired, and the treatment reduced signs of cellular damage (oxidative stress) and improved the health of mitochondria—the energy-producing structures inside muscle cells. This suggests ginseng compounds might help fight fatigue by protecting cells from damage.
Understanding potential mechanisms underlying fatigue—such as oxidative stress and mitochondrial dysfunction—is crucial for ME/CFS research, as these cellular processes are hypothesized to contribute to the disease. If validated in humans, ginseng compounds targeting these pathways could represent a novel therapeutic avenue. This work contributes to the growing evidence that metabolic and cellular mechanisms play roles in chronic fatigue conditions.
This study does not prove that ginseng polysaccharides are an effective treatment for humans with ME/CFS; it is an animal model study that cannot directly translate to clinical benefit. It does not establish causation between oxidative stress and CFS, only a correlation in treated mice. The study does not rule out alternative explanations for the observations or compare WGPA-A efficacy against other potential treatments.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →